Trading Signals: BMY Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(Bristol-Myers Squibb Company)
| BMY latest price $56.4184 (0.1%) ($56.2706 - $57.6561) on Wed. Feb. 10, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.63% (three month average) | RSI | 41 | Latest Price | $56.4184(0.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BMY advances 0.3% a day on average for past five trading days. | Weekly Trend | BMY declines -1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BMY advance at 0% a week (0% probability) XLV(54%) VYM(43%) IBB(41%) IVE(41%) IWD(40%) | Factors Impacting BMY price | BMY will decline at least -0.815% in a week (0% probabilities). VIXM(-18%) TLT(-12%) UUP(-8%) SHY(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.815% (StdDev 1.63%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
1 - 5 Day Possible Target | $51.4(-8.89%) | Resistance Level | $56.95 | 5 Day Moving Average | $55.82(1.07%) | 10 Day Moving Average | $55.9(0.93%) | 20 Day Moving Average | $56.95(-0.93%) | To recent high | -13.1% | To recent low | 3.8% | Market Cap | $127.163b | | | | Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |